Literature DB >> 18433705

Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?

Dolores Subirá1, Patricia Font, Lucia Villalón, Cristina Serrano, Elham Askari, Elena Góngora, Susana Castañón, Raquel Gonzalo, Raquel Mata, Alejandro Román, Pilar Llamas.   

Abstract

Chronic myelomonocytic leukemia (CMML) is a heterogeneous disease balanced between myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). We used flow cytometry to describe and compare the immunophenotypic profile of 20 patients with CMML, 38 patients with MDS, and 20 patients with MPD. CMML and MDS only showed statistically significant differences (P<0.05) in CD56 monocyte expression. CMML and MPD showed significant differences in CD45 myeloid distribution, myeloid antigenic profile, CD56 and CD2 monocyte expression, and B-cell development. These data support the classic concept of CMML as part of MDS diseases and encourage including immunophenotyping among the studies to be performed in these diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433705     DOI: 10.1016/j.trsl.2008.03.001

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  4 in total

1.  Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.

Authors:  Dorothée Selimoglu-Buet; Orianne Wagner-Ballon; Véronique Saada; Valérie Bardet; Raphaël Itzykson; Laura Bencheikh; Margot Morabito; Elisabeth Met; Camille Debord; Emmanuel Benayoun; Anne-Marie Nloga; Pierre Fenaux; Thorsten Braun; Christophe Willekens; Bruno Quesnel; Lionel Adès; Michaela Fontenay; Philippe Rameau; Nathalie Droin; Serge Koscielny; Eric Solary
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

2.  Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Authors:  Arjan A van de Loosdrecht; Canan Alhan; Marie Christine Béné; Matteo G Della Porta; Angelika M Dräger; Jean Feuillard; Patricia Font; Ulrich Germing; Detlef Haase; Christa H Homburg; Robin Ireland; Joop H Jansen; Wolfgang Kern; Luca Malcovati; Jeroen G Te Marvelde; Ghulam J Mufti; Kiyoyuki Ogata; Alberto Orfao; Gert J Ossenkoppele; Anna Porwit; Frank W Preijers; Stephen J Richards; Gerrit Jan Schuurhuis; Dolores Subirá; Peter Valent; Vincent H J van der Velden; Paresh Vyas; August H Westra; Theo M de Witte; Denise A Wells; Michael R Loken; Theresia M Westers
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

3.  Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.

Authors:  Tiphanie Picot; Carmen Mariana Aanei; Pascale Flandrin Gresta; Pauline Noyel; Sylvie Tondeur; Emmanuelle Tavernier Tardy; Denis Guyotat; Lydia Campos Catafal
Journal:  Front Oncol       Date:  2018-04-12       Impact factor: 6.244

4.  Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia.

Authors:  Uta Oelschlägel; Malte von Bonin; Maximilian A Röhnert; Michael Kramer; Jonas Schadt; Philipp Ensel; Christian Thiede; Stefan W Krause; Veit Bücklein; Jörg Hoffmann; Sonia Jaramillo; Richard F Schlenk; Christoph Röllig; Martin Bornhäuser; Nicholas McCarthy; Sylvie Freeman
Journal:  Leukemia       Date:  2022-07-18       Impact factor: 12.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.